FDA accepts Merck application for lung cancer combo therapy

Merck & Co on Tuesday said the FDA agreed to a speedy review of its application to combine its immunotherapy drug Keytruda with chemotherapy as an initial treatment for advanced lung cancer, potentially giving it a major leg up in the competition for the largest cancer market....
8 Published By - Channel NewsAsia Front Page News - 2017.01.10. 23:30
Share |